Dr. Michael Lynes Selected as Fulbright Scholar

Dr. Michael Lynes was recently selected to be a Fulbright Scholar and will work at the Center for Diabetes Research, University of Bergen (Norway) for the fall 2020 semester. He was also made a Senior Fellow of the Cell Stress Society International. Dr. Lynes has recently been awarded two new research grants: an NIH phase II STTR grant entitled “Measuring toxicant effects on cellular function in a microarray format” and a sponsored research award from Biohaven Pharmaceuticals to support the ongoing development of a therapeutic monoclonal antibody for chronic inflammation applications entitled “Characterization of UC1MT therapeutic antibody and its derivatives”.